2m 2m 2m 2m 2m 2m 2m
IMUNON (IMNN)
NASDAQ
$2.11+$0.01 (+0.67%)
Price as of Jun 03, 2026 7:59 PM EDT- $9.2MMarket Cap
- -91.41%1-Year Change
- BiotechnologyIndustry
IMUNON (IMNN)
$2.11+$0.01 (+0.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | N/A N/A | N/A N/A | -34,302 -106.86% | 500,000 0.00% | |
Cost of Revenue | N/A N/A | 1.4M N/A | N/A N/A | 1.9M -44.12% | |
Gross Profit | 0 +100.00% | -1.4M +3,940.58% | -34,302 -97.55% | -1.4M -51.72% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -7.8M -33.15% | -11.6M +3.12% | -11.3M -3.80% | -11.7M +10.49% | |
Depreciation and Amortization Expense | 291,908 +21.54% | 240,175 -3.22% | 248,154 -66.08% | 731,629 +4.08% | |
Total Operating Expenses | 14.7M -23.42% | 19.1M -9.02% | 21.0M -17.27% | 25.4M +18.20% | |
Operating Profit | -14.7M -23.42% | -19.1M -9.02% | -21.0M -15.61% | -24.9M +18.63% | |
Interest Income | N/A N/A | 61,983 -91.46% | 725,824 +44.42% | 502,578 +2,669.79% | |
Interest Expense | N/A N/A | -334,212 +69.58% | -197,080 -96.08% | -5.0M +782.40% | |
Interest Income and Expense and Net | 0 +100.00% | -272,229 -151.49% | 528,744 +111.68% | -4.5M +720.33% | |
Total Nonoperating Income and Expense | 155,666 -69.61% | 512,204 +117.90% | 235,068 +101.87% | -12.5M +995.04% | |
Income before Taxes | -14.7M -21.32% | -18.6M -10.46% | -20.8M -44.49% | -37.5M +69.12% | |
Income Taxes | N/A N/A | 1.3M +200.00% | -1.3M -18.29% | -1.6M +13.27% | |
Extraordinary Items | N/A N/A | N/A N/A | 13.4M 0.00% | 13.4M N/A | |
Net Income | N/A N/A | -18.6M -4.58% | -19.5M -45.64% | -35.9M +72.84% | |
Net Income from Continuing Operations Applicable to Common | 14.5M +177.87% | -18.6M -10.46% | -20.8M -44.49% | -37.5M +69.12% | |
Basic EPS and Net Income | -6.83 +321.60% | -1.62 -25.00% | -2.16 -57.06% | -5.03 +31.33% | |
Diluted EPS and Net Income | -6.83 +321.60% | -1.62 -25.00% | -2.16 -57.06% | -5.03 +31.33% | |
Basic Weighted Average Shares | 2.1M -81.55% | 11.5M +27.23% | 9.0M +26.63% | 7.1M +31.62% | |
Diluted Weighted Average Shares | 2.1M -81.55% | 11.5M +27.23% | 9.0M +26.63% | 7.1M +31.62% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 8.8M +49.52% | 5.9M +0.59% | 5.8M -49.20% | 11.5M -41.32% | |
Short-Term Investments | N/A N/A | N/A N/A | 9.9M -53.62% | 21.3M -28.68% | |
Cash and Cash Equivalents and Short-Term Investments | 8.8M +49.52% | 5.9M -62.58% | 15.7M -52.07% | 32.7M -33.70% | |
Total Current Assets | 10.7M +33.90% | 8.0M -56.09% | 18.2M -50.91% | 37.2M -28.47% | |
Accumulated Depreciation | 1.3M +6.66% | 1.2M -43.10% | 2.1M -20.48% | 2.6M -21.22% | |
Property and Plant and Equipment and Net | 529,936 -2.09% | 541,272 -28.01% | 751,906 +37.13% | 548,301 +14.95% | |
Total Long-Term Assets | 1.0M -11.37% | 1.2M -60.10% | 2.9M -53.36% | 6.3M -70.99% | |
Total Assets | 12.3M +26.46% | 9.7M -55.67% | 21.9M -50.16% | 44.0M -40.61% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | 6.4M 0.00% | 6.4M +350.60% | 1.4M -85.75% | |
Total Current Liabilities | 4.6M -3.39% | 4.8M -35.24% | 7.4M -26.36% | 10.0M +48.27% | |
Total Long-Term Debt | N/A N/A | 375,000 0.00% | 375,000 -91.87% | 4.6M -21.24% | |
Total Long-Term Liabilities | 602,411 -12.30% | 686,935 -39.71% | 1.1M -75.29% | 4.6M -24.23% | |
Total Liabilities | 5.2M -4.51% | 5.5M -35.84% | 8.5M -41.76% | 14.6M -19.74% | |
Retained Earnings | -421.3M +3.56% | -406.8M +4.80% | -388.2M +5.29% | -368.7M +10.79% | |
Total Stockholders Equity | 7.1M +68.39% | 4.2M -68.30% | 13.4M -54.35% | 29.3M -47.44% | |
Total Shares Outstanding | 3.4M -76.42% | 14.5M +54.27% | 9.4M +26.41% | 7.4M +28.87% | |
Cash Flow | |||||
Cash from Operating Activities | -13.9M -26.30% | -18.9M -0.88% | -19.0M -17.76% | -23.1M +42.58% | |
Capital Expenditures | 280,572 +849.77% | 29,541 -93.46% | 451,759 +68.69% | 267,800 -14.06% | |
Cash from Investing Activities | -280,572 -102.85% | 9.8M -10.70% | 11.0M +32.36% | 8.3M +127.60% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 17.1M +88.57% | 9.1M +349.01% | -3.6M -154.12% | 6.7M -87.73% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | -280.00% -51.72% | |
Operating Margin | N/A N/A | N/A N/A | 61,309.63% +1,330.05% | -4,984.31% +18.63% | |
Return on Assets | N/A N/A | -117.72% +98.74% | -59.23% -2.63% | -60.83% +63.40% | |
Return on Equity | N/A N/A | -211.21% +131.15% | -91.37% +8.33% | -84.34% +51.08% | |
Revenue Growth | N/A N/A | N/A N/A | -106.86% N/A | 0.00% N/A | |
Current Ratio | 2.32 +38.59% | 1.67 -32.19% | 2.47 -33.33% | 3.70 -51.76% | |
Cash Ratio | 1.90 +54.78% | 1.23 +55.34% | 0.79 -31.01% | 1.15 -60.42% | |
Debt-to-Equity Ratio | N/A N/A | 1.60 +215.41% | 0.51 +146.65% | 0.21 -27.59% | |
Debt-to-Assets Ratio | N/A N/A | 0.70 +125.58% | 0.31 +125.78% | 0.14 -35.87% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow